Zoladex
High Grade Glioma
Nationwide Children's HospitalPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
20 Active assets in the High Grade Glioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dabrafenib National Cancer Institute (NCI) | Phase 4 | B |
FULVESTRANT Nationwide Children's Hospital | Phase 2 | B |
Letrozole Nationwide Children's Hospital | Phase 2 | B |
db107-rrv University of California, San Francisco | Phase 2 | B |
LEUPROLIDE Nationwide Children's Hospital | Phase 2 | B |
View all 33 →
Same molecule, other indications
Zoladex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →